Biotech SF
San Francisco Bay Area biotech stories.
Monday, March 7, 2011
Exelixis to sell 14.4 million shares
Striking while its drug is hot, Exelixis Inc. could raise around $160 million by selling nearly 14.4 million shares from a previous shelf registration of stock.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment